[HTML][HTML] Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
With more than 5 million fatalities and close to 300 million reported cases, COVID-19 is the
first documented pandemic due to a coronavirus that continues to be a major health …
first documented pandemic due to a coronavirus that continues to be a major health …
Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery
Drug development is expensive, time-consuming, and has a high failure rate. In recent
years, artificial intelligence (AI) has emerged as a transformative tool in drug discovery …
years, artificial intelligence (AI) has emerged as a transformative tool in drug discovery …
Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
Drug repurposing is an important approach to the assignment of already approved drugs for
new indications. This technique bypasses some steps in the traditional drug approval …
new indications. This technique bypasses some steps in the traditional drug approval …
Naturally available flavonoid aglycones as potential antiviral drug candidates against SARS-CoV-2
Flavonoids are important secondary plant metabolites that have been studied for a long time
for their therapeutic potential in inflammatory diseases because of their cytokine-modulatory …
for their therapeutic potential in inflammatory diseases because of their cytokine-modulatory …
In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus
Seasonal human influenza is a serious respiratory infection caused by influenza viruses that
can be found all over the world. Type A influenza is a contagious viral infection that, if left …
can be found all over the world. Type A influenza is a contagious viral infection that, if left …
In vitro potential antiviral SARS-CoV-19-activity of natural product thymohydroquinone and dithymoquinone from Nigella sativa
Inflammation, oxidation, and compromised immunity all increase the dangers of COVID-19,
whereas many pharmaceutical protocols may lead to increased immunity such as ingesting …
whereas many pharmaceutical protocols may lead to increased immunity such as ingesting …
Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
O Kutkat, Y Moatasim, AA Al‐Karmalawy… - Scientific Reports, 2022 - nature.com
During the current coronavirus disease 2019 (COVID-19) pandemic, symptoms of
depression are commonly documented among both symptomatic and asymptomatic …
depression are commonly documented among both symptomatic and asymptomatic …
Bioactive Azadirachta indica and Melia azedarach leaves extracts with anti-SARS-CoV-2 and antibacterial activities
BA Hemdan, A Mostafa, MM Elbatanony, AM El-Feky… - PLoS …, 2023 - journals.plos.org
The leaves of Azadirachta indica L. and Melia azedarach L., belonging to Meliaceae family,
have been shown to have medicinal benefits and are extensively employed in traditional folk …
have been shown to have medicinal benefits and are extensively employed in traditional folk …
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
JF Rossignol, MC Bardin, J Fulgencio… - …, 2022 - thelancet.com
Background There is an urgent need for treatments of mild or moderate COVID-19 in an
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …
outpatient setting. Methods A randomized double-blind placebo-controlled clinical trial in 36 …
为了回应用户根据美国数字千年版权法案 (DMCA) 向我们提交的投诉,我们已从此页上移除了 2 个结果。如果需要,您可以访问 LumenDatabase.org,查看导致结果遭到移除的 DMCA 投诉内容。